NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Xperi Corporation (NASDAQ: XPER) and TiVo Corporation (NASDAQ: TIVO)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Xperi Corporation (NASDAQ: XPER) and TiVo Corporation (NASDAQ: TIVO) in connection with the proposed merger of the two companies. Under the terms of the merger agreement, the shares of XPER and TIVO stockholders will be converted into shares of a new parent company based on a fixed exchange ratio of 0.455 XPER share per existing TIVO share. Upon completion of the merger, TIVO stockholders will own 53.5% and XPER stockholders will own 46.5% of the new parent company. If you own XPER or TIVO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/xperi-and-tivo-corporations-investigation/
Wright Medical Group N.V. (NASDAQ: WMGI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Wright Medical Group N.V. (NASDAQ: WMGI) in connection with the proposed acquisition of the Company by Stryker Corporation (“SYK”). Under the terms of the acquisition agreement, SYK has commenced a tender offer (the “Tender Offer”) to acquire all outstanding WMGI shares for $30.75 in cash. The Tender Offer, which was originally set to expire on February 27, 2020, has been extended to April 30, 2020. If you own WMGI shares and wish to discuss this investigation or your rights, or you have questions about tendering your shares, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/wright-medical-group-nv/
Pope Resources, A Delaware Limited Partnership (NASDAQ: POPE)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pope Resources, A Delaware Limited Partnership (NASDAQ: POPE) in connection with the proposed acquisition of POPE by Rayonier Inc. (“RYN”). Under the terms of the acquisition agreement, POPE unitholders can elect to receive either: (i) $125 in cash, (ii) 3.29 shares of RYN common stock, or (iii) 3.929 units of Rayonier Operating Partnership LP for each unit of POPE they own, subject to a proration mechanism which will adjust and prorate the cash and equity portions of the merger consideration to ensure that each POPE unitholder will receive compensation equal to amounts as if every POPE unit received 2.751 Rayonier common shares or Rayonier operating partnership units and $37.50 in cash. In accordance with the proration mechanism, the current value of the per-unit merger consideration for POPE unitholders is approximately $101.48 based upon RYN’s March 30, 2020 closing price of $23.26. If you own POPE shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/pope-resources/
